Genome-wide Association Study of Varicose Veins Identifies a Protective Missense Variant in GJD3 Enriched in the Finnish Population

Overview

Journal Commun Biol

Specialty Biology

Date 2023 Jan 18

PMID 36653477

Authors

Pyry Helkkula

Shabbeer Hassan

Elmo Saarentaus

Emilia Vartiainen

Sanni Ruotsalainen

Jaakko T Leinonen

Aarno Palotie

Juha Karjalainen

Mitja Kurki

Samuli Ripatti

Taru Tukiainen

Affiliations

Soon will be listed here.

Abstract

Varicose veins is the most common manifestation of chronic venous disease that displays female-biased incidence. To identify protein-inactivating variants that could guide identification of drug target genes for varicose veins and genetic evidence for the disease prevalence difference between the sexes, we conducted a genome-wide association study of varicose veins in Finns using the FinnGen dataset with 17,027 cases and 190,028 controls. We identified 50 associated genetic loci (P < 5.0 × 10) of which 29 were novel including one near ERG with female-specificity (rs2836405-G, OR[95% CI] = 1.09[1.05-1.13], P = 3.1 × 10). These also include two X-chromosomal (ARHGAP6 and SRPX) and two autosomal novel loci (TGFB2 and GJD3) with protein-coding lead variants enriched above 56-fold in Finns over non-Finnish non-Estonian Europeans. A low-frequency missense variant in GJD3 (p.Pro59Thr) is exclusively associated with a lower risk for varicose veins (OR = 0.62 [0.55-0.70], P = 1.0 × 10) in a phenome-wide scan of the FinnGen data. The absence of observed pleiotropy and its membership of the connexin gene family underlines GJD3 as a potential connexin-modulating therapeutic strategy for varicose veins. Our results provide insights into varicose veins etiopathology and highlight the power of isolated populations, including Finns, to discover genetic variants that inform therapeutic development.

Citing Articles

Omics Data Integration Uncovers mRNA-miRNA Interaction Regions in Genes Associated with Chronic Venous Insufficiency.

Sari-Tunel F, Demirkan A, Vural B, Yildiz C, Komurcu-Bayrak E Genes (Basel). 2025; 16(1).

PMID: 39858587 PMC: 11765502. DOI: 10.3390/genes16010040.

A rare haplotype of the GJD3 gene segregating in familial Meniere's disease interferes with connexin assembly.

Escalera-Balsera A, Robles-Bolivar P, Parra-Perez A, Murillo-Cuesta S, Chua H, Rodriguez-de la Rosa L Genome Med. 2025; 17(1):4.

PMID: 39815343 PMC: 11737067. DOI: 10.1186/s13073-024-01425-1.

Exome sequencing identifies novel genetic variants associated with varicose veins.

Zhang D, He X, Yang L, Wu B, Fu Y, Liu W PLoS Genet. 2024; 20(7):e1011339.

PMID: 38980841 PMC: 11233024. DOI: 10.1371/journal.pgen.1011339.

Replication study identified EFEMP1 association with varicose vein predisposition among Indians.

Mehra R, Patra V, Dhillan R, Sharma A, Kashyap S, Rastogi G Eur J Med Res. 2024; 29(1):232.

PMID: 38609985 PMC: 11015598. DOI: 10.1186/s40001-024-01786-8.

Sex hormone-binding globulin exerts sex-related causal effects on lower extremity varicose veins: evidence from gender-stratified Mendelian randomization.

Fan Q, Meng Y, Nie Z, Xie S, Chen C Front Endocrinol (Lausanne). 2023; 14:1230955.

PMID: 38152135 PMC: 10752419. DOI: 10.3389/fendo.2023.1230955.

References

Criqui M, Jamosmos M, Fronek A, Denenberg J, Langer R, Bergan J . Chronic venous disease in an ethnically diverse population: the San Diego Population Study. Am J Epidemiol. 2003; 158(5):448-56. PMC: 4285442. DOI: 10.1093/aje/kwg166. View

Ahmed W, Kleeman S, Ng M, Wang W, Auton A, Lee R . Genome-wide association analysis and replication in 810,625 individuals with varicose veins. Nat Commun. 2022; 13(1):3065. PMC: 9163161. DOI: 10.1038/s41467-022-30765-y. View

Lurie F, Passman M, Meisner M, Dalsing M, Masuda E, Welch H . The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020; 8(3):342-352. DOI: 10.1016/j.jvsv.2019.12.075. View

van Vliet H, Frolich M, Christella M, Thomassen L, Doggen C, Rosendaal F . Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens. Hum Reprod. 2004; 20(2):563-8. DOI: 10.1093/humrep/deh612. View

Kowalewski R, Malkowski A, Sobolewski K, Gacko M . Evaluation of transforming growth factor-beta signaling pathway in the wall of normal and varicose veins. Pathobiology. 2010; 77(1):1-6. DOI: 10.1159/000272948. View

Bernabeu E, Canela-Xandri O, Rawlik K, Talenti A, Prendergast J, Tenesa A . Sex differences in genetic architecture in the UK Biobank. Nat Genet. 2021; 53(9):1283-1289. DOI: 10.1038/s41588-021-00912-0. View

Chiesa R, Marone E, Limoni C, Volonte M, Schaefer E, Petrini O . Chronic venous insufficiency in Italy: the 24-cities cohort study. Eur J Vasc Endovasc Surg. 2005; 30(4):422-9. DOI: 10.1016/j.ejvs.2005.06.005. View

Lindsay M, Schepers D, Bolar N, Doyle J, Gallo E, Fert-Bober J . Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet. 2012; 44(8):922-7. PMC: 3616632. DOI: 10.1038/ng.2349. View

Robertson L, Evans C, Fowkes F . Epidemiology of chronic venous disease. Phlebology. 2008; 23(3):103-11. DOI: 10.1258/phleb.2007.007061. View

10.

Sinnott-Armstrong N, Tanigawa Y, Amar D, Mars N, Benner C, Aguirre M . Genetics of 35 blood and urine biomarkers in the UK Biobank. Nat Genet. 2021; 53(2):185-194. PMC: 7867639. DOI: 10.1038/s41588-020-00757-z. View

11.

Ruotsalainen S, Surakka I, Mars N, Karjalainen J, Kurki M, Kanai M . Inframe insertion and splice site variants in MFGE8 associate with protection against coronary atherosclerosis. Commun Biol. 2022; 5(1):802. PMC: 9385630. DOI: 10.1038/s42003-022-03552-0. View

12.

Abecasis G, Altshuler D, Auton A, Brooks L, Durbin R, Gibbs R . A map of human genome variation from population-scale sequencing. Nature. 2010; 467(7319):1061-73. PMC: 3042601. DOI: 10.1038/nature09534. View

13.

van Rooijen M, Silveira A, Hamsten A, Bremme K . Sex hormone--binding globulin--a surrogate marker for the prothrombotic effects of combined oral contraceptives. Am J Obstet Gynecol. 2004; 190(2):332-7. DOI: 10.1016/s0002-9378(03)00950-5. View

14.

Reglinska-Matveyev N, Andersson H, Rezende S, Dahlback B, Crawley J, Lane D . TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain. Blood. 2014; 123(25):3979-87. PMC: 4064334. DOI: 10.1182/blood-2014-01-551812. View

15.

Kassam I, Lloyd-Jones L, Holloway A, Small K, Zeng B, Bakshi A . Autosomal genetic control of human gene expression does not differ across the sexes. Genome Biol. 2016; 17(1):248. PMC: 5134098. DOI: 10.1186/s13059-016-1111-0. View

16.

Hirai M, Naiki K, Nakayama R . Prevalence and risk factors of varicose veins in Japanese women. Angiology. 1990; 41(3):228-32. DOI: 10.1177/000331979004100308. View

17.

Shadrina A, Sharapov S, Shashkova T, Tsepilov Y . Varicose veins of lower extremities: Insights from the first large-scale genetic study. PLoS Genet. 2019; 15(4):e1008110. PMC: 6490943. DOI: 10.1371/journal.pgen.1008110. View

18.

McLaren W, Gil L, Hunt S, Riat H, Ritchie G, Thormann A . The Ensembl Variant Effect Predictor. Genome Biol. 2016; 17(1):122. PMC: 4893825. DOI: 10.1186/s13059-016-0974-4. View

19.

Fukaya E, Flores A, Lindholm D, Gustafsson S, Zanetti D, Ingelsson E . Clinical and Genetic Determinants of Varicose Veins. Circulation. 2018; 138(25):2869-2880. PMC: 6400474. DOI: 10.1161/CIRCULATIONAHA.118.035584. View

20.

Gudbjartsson D, Helgason H, Gudjonsson S, Zink F, Oddson A, Gylfason A . Large-scale whole-genome sequencing of the Icelandic population. Nat Genet. 2015; 47(5):435-44. DOI: 10.1038/ng.3247. View